haloprogin has been researched along with Dysplastic Nevus Syndrome, Hereditary in 1 studies
haloprogin: minor descriptor (73-86); on-line & INDEX MEDICUS search PHENYL ETHERS (73-86)
| Excerpt | Relevance | Reference |
|---|---|---|
| " The combination with the repurposed chemodrug haloprogin provides the basis for a new powerful treatment option for cutaneous melanoma." | 1.48 | Drug Repurposing Approach Identifies a Synergistic Drug Combination of an Antifungal Agent and an Experimental Organometallic Drug for Melanoma Treatment. ( Demaria, O; Dyson, PJ; Gilliet, M; Joncic, A; Riedel, T; Zava, O, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Riedel, T | 1 |
| Demaria, O | 1 |
| Zava, O | 1 |
| Joncic, A | 1 |
| Gilliet, M | 1 |
| Dyson, PJ | 1 |
1 other study available for haloprogin and Dysplastic Nevus Syndrome, Hereditary
| Article | Year |
|---|---|
Drug Repurposing Approach Identifies a Synergistic Drug Combination of an Antifungal Agent and an Experimental Organometallic Drug for Melanoma Treatment.
Topics: Animals; Antifungal Agents; Antineoplastic Agents; Cell Survival; Drug Repositioning; Drug Synergism | 2018 |